AU3063899A - Use of il-10 to treat major depressive disorder - Google Patents

Use of il-10 to treat major depressive disorder

Info

Publication number
AU3063899A
AU3063899A AU30638/99A AU3063899A AU3063899A AU 3063899 A AU3063899 A AU 3063899A AU 30638/99 A AU30638/99 A AU 30638/99A AU 3063899 A AU3063899 A AU 3063899A AU 3063899 A AU3063899 A AU 3063899A
Authority
AU
Australia
Prior art keywords
depressive disorder
major depressive
treat major
treat
disorder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30638/99A
Inventor
Paul Glue
Newell Mcelwee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of AU3063899A publication Critical patent/AU3063899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU30638/99A 1998-03-17 1999-03-16 Use of il-10 to treat major depressive disorder Abandoned AU3063899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4297598A 1998-03-17 1998-03-17
US09042975 1998-03-17
PCT/US1999/003743 WO1999047157A1 (en) 1998-03-17 1999-03-16 Use of il-10 to treat major depressive disorder

Publications (1)

Publication Number Publication Date
AU3063899A true AU3063899A (en) 1999-10-11

Family

ID=21924773

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30638/99A Abandoned AU3063899A (en) 1998-03-17 1999-03-16 Use of il-10 to treat major depressive disorder

Country Status (2)

Country Link
AU (1) AU3063899A (en)
WO (1) WO1999047157A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7261882B2 (en) 2003-06-23 2007-08-28 Reagents Of The University Of Colorado Methods for treating neuropathic pain by administering IL-10 polypeptides
SI2816118T1 (en) 2005-05-31 2019-01-31 The Regents Of The University Of Colorado, A Body Corporate Methods for delivering genes
US10512672B2 (en) 2013-07-18 2019-12-24 Xalud Therapeutics, Inc. Methods for the treatment of inflammatory joint disease

Also Published As

Publication number Publication date
WO1999047157A1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
GB9824436D0 (en) Methods of treatment
ZA986822B (en) Reduction of hair growth
GB9814377D0 (en) Treatment of airborne microorganisms
AUPM761094A0 (en) Treatment of hides
AU9489898A (en) Method to enhance the antibacterial efficacy of antibacterial dentifrices
AU3784999A (en) Methods for treatment of pain
AU2836499A (en) Cosmetic method of treating skin
AU2512501A (en) Use of trimebutine for treating pain
AUPO871397A0 (en) Improved treatment of hides
PL345110A1 (en) Aza-heterocyclic compounds used to treat neurological disorders and hair loss
GB2336157B (en) The use of DNA fragments to treat dermatological conditions
AU3063899A (en) Use of il-10 to treat major depressive disorder
EP0755255A4 (en) Treatment of toxoplasmosis
AU5425098A (en) Compounds and methods to treat infectious diseases
AU2798299A (en) Therapeutic and prophylactic uses of negatively charged substituted disaccharides
AU2500997A (en) Use of prostaglandins to treat ataxia telangiectasia
AU5812601A (en) Treatment of il-10 deficiencies
GB2353217B (en) Use of ribose to treat fibromyalgia
GB2343629B (en) Treatment of cellulite
AU5432599A (en) Treatment of vasodilatory headache
AU5251499A (en) Compositions and methods useful for treatment of depressive disorder based on ananimal model
AU6045198A (en) Use of il-4 and/or il-10 to treat proliferative glomerulonephritis
AU5294499A (en) Treatment of hair loss
PL346528A1 (en) Treatment of depression
GB9709451D0 (en) Treatment of allergic conditions

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase